Lentinan as an immunotherapeutic for treating lung cancer: a review of 12 years clinical studies in China
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Lentinan as an immunotherapeutic for treating lung cancer: a review of 12 years clinical studies in China
Authors
Keywords
Cancer, Chemotherapy, Immunobalance, Immunostimulant, Lentinan
Journal
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2018-07-24
DOI
10.1007/s00432-018-2718-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pathological complete response and prognosis after neoadjuvant chemotherapy for HER2-positive breast cancers before and after trastuzumab era: results from a real-life cohort
- (2018) Anne-Sophie Hamy et al. BRITISH JOURNAL OF CANCER
- Fungal mediated innate immune memory, what have we learned?
- (2018) Jessica Quintin SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Cumulative experience and long term follow-up of pentostatin-based chemoimmunotherapy trials for patients with chronic lymphocytic leukemia
- (2018) Neil E. Kay et al. Expert Review of Hematology
- Chemotherapy-induced immunomodulation in non-small-cell lung cancer: a rationale for combination chemoimmunotherapy
- (2017) Hua Zheng et al. Immunotherapy
- Complete response of metastatic gastric cancer to chemoimmunotherapy
- (2017) Kenji Ina et al. INDIAN JOURNAL OF MEDICAL RESEARCH
- Impact of (chemo)radiotherapy on immune cell composition and function in cervical cancer patients
- (2017) H. van Meir et al. OncoImmunology
- Anti-diabetic polysaccharides from natural sources: A review
- (2016) Peng-Cheng Wang et al. CARBOHYDRATE POLYMERS
- Mushroom heteropolysaccharides: A review on their sources, structure and biological effects
- (2016) Andrea C. Ruthes et al. CARBOHYDRATE POLYMERS
- β-Glucan Reverses the Epigenetic State of LPS-Induced Immunological Tolerance
- (2016) Boris Novakovic et al. CELL
- In VitroExperimental Model of Trained Innate Immunity in Human Primary Monocytes
- (2016) Siroon Bekkering et al. Clinical and Vaccine Immunology
- Activation of the NRF2-ARE signalling pathway by the Lentinula edodes polysaccharose LNT alleviates ROS-mediated cisplatin nephrotoxicity
- (2016) Qian Chen et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Lentinan exerts synergistic apoptotic effects with paclitaxel in A549 cellsviaactivating ROS-TXNIP-NLRP3 inflammasome
- (2015) Wei Liu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Induction of apoptosis in S180 tumour bearing mice by polysaccharide from Lentinus edodes via mitochondria apoptotic pathway
- (2015) Yu Zhang et al. Journal of Functional Foods
- Molecular Markers for Breast Cancer: Prediction on Tumor Behavior
- (2014) Bruna Karina Banin Hirata et al. DISEASE MARKERS
- Radiation therapy: A major factor in the five-year survival analysis of women with breast cancer in Lagos, Nigeria
- (2014) Samira B.L. Makanjuola et al. RADIOTHERAPY AND ONCOLOGY
- mTOR- and HIF-1 -mediated aerobic glycolysis as metabolic basis for trained immunity
- (2014) S.-C. Cheng et al. SCIENCE
- Emerging Therapies for Glioblastoma
- (2014) Alissa A. Thomas et al. JAMA Neurology
- The Use of Lentinan for Treating Gastric Cancer
- (2013) Kenji Ina et al. Anti-Cancer Agents in Medicinal Chemistry
- Intestinal Anti-Inflammatory Activity of Lentinan: Influence on IL-8 and TNFR1 Expression in Intestinal Epithelial Cells
- (2013) Yosuke Nishitani et al. PLoS One
- Candida albicans Infection Affords Protection against Reinfection via Functional Reprogramming of Monocytes
- (2012) Jessica Quintin et al. Cell Host & Microbe
- Immunomodulatory β-Glucan fromLentinus edodesActivates Mitogen-activated Protein Kinases and Nuclear Factor-κB in Murine RAW 264.7 Macrophages
- (2011) Xiaojuan Xu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Immune modulating effects of β-glucan
- (2010) E Angela Murphy et al. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now